A study conducted by the Canadian company Canabo Medical, Inc., has found 40% of its patients have been able to eliminate their use of benzodiazepines within 90 days of beginning medical marijuana treatment. After a year, 45% of its patients were able to quit their use of prescription medications. Canabo and a team of researchers looked at data from 1,500 patients to establish a link between medical marijuana and the need for pharmaceutical medications. Early results, which were confirmed by ongoing research, found medical cannabis treatments that were supervised by a physician resulted in a significant drop in benzodiazepine reliance. This study then followed a group 146 patients suffering pain and other disorders for one year. Canabo chairman Dr. Neil Smith says of the study, “To say that we’re encouraged is an understatement, but there’s a lot of work still left to be done... We hope to conduct formal trials both in-house and in collaboration with others, pending further analysis of what we believe to be one of the most promising advancements in many years.”
This information has been provided by High Times Magazine and approved by our Chief Medical Officer.